PENTOSTATIN IN RENAL DYSFUNCTION IN CANCER PATIENTS

喷司他汀治疗癌症患者肾功能不全

• 批准号: 6245566
• 负责人: GINI F. FLEMING
• 金额: $ 3.72万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-06 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6245566
• 关键词: clinical research; deoxycoformycin; drug adverse effect; drug screening /evaluation; human subject; kidney disorder; kidney pharmacology; neoplasm /cancer; neoplasm /cancer chemotherapy; pharmacokinetics

This study will determine the pharmocokinetics and assess the toxicity of pentostatin in cancer patients with varying degrees of renal dysfunction.

本研究将测定其药代动力学并评估其毒性。 有不同程度肾功能障碍的癌症患者。